
FDA Expands GSK’s Arexvy Approval to Younger Adults at Elevated RSV Risk
As reported on PharmaBiz, the US Food and Drug Administration has broadened the approved use of GSK’s respiratory syncytial virus (RSV) vaccine, Arexvy, to include


As reported on PharmaBiz, the US Food and Drug Administration has broadened the approved use of GSK’s respiratory syncytial virus (RSV) vaccine, Arexvy, to include

Editor’s Note: The following in from author Stephen Policoff, whose book A Ribbon for Your Hair is out today! Introduction When Stephen Policoff’s adopted daughter

A New Solution to Address Critical Gaps in Glioma Diagnosis and Management Telix Pharmaceuticals, a biopharmaceutical company specializing in therapeutic and diagnostic radiopharmaceuticals, has taken

As reported on Healio, a novel biologic targeting two key angiogenic pathways has shown encouraging early results for the treatment of wet age-related macular degeneration

Editor’s Note: This story is a continuation of Jenny Decker’s global sailing voyage. To see the original article, please click here. Many of our Patient

AstraZeneca has received European Commission approval for Imfinzi (durvalumab) in combination with FLOT chemotherapy, a landmark achievement representing the first immunotherapy-based regimen to demonstrate survival

People with rare and chronic disease often suffer from long term pain. New ways to alleviate this pain are needed. According to a press release

“Do not go gentle into that good night. Rage, rage against the dying of the light.” –Dylan Thomas One may have thought, after six months

In a recent press release, Structure Therapeutics has reported encouraging topline results from its Phase 2 ACCESS clinical program evaluating aleniglipron, an investigational once-daily oral

As reported on Inside Precision Medicine, scientists in Germany have made an exciting discovery that could help children with a very rare and serious illness

The biotechnology sector witnessed a striking demonstration of expedited drug development this week, with Boehringer Ingelheim receiving FDA approval for an innovative lung cancer therapy

As reported by Pharma Times, Elevara Medicines has initiated a phase 2b clinical study evaluating ELV001, an investigational oral CDK4/6 inhibitor, in people with rheumatoid

Pictured above: Giuliana Noratto, Ph.D., (left) and Lauren Stranahan, Ph.D., led research showing that compounds in dark sweet cherries may help slow the growth and

Daiichi Sankyo has taken a significant step toward expanding treatment options in Japan by submitting regulatory approval for Enhertu, an advanced cancer-fighting drug designed to

As reported by FiercePharma, the U.S. Food and Drug Administration has approved the first fully independent generic version of GlaxoSmithKline’s widely used asthma inhaler, Flovent,

You can not see, hear, or touch my rare condition. I STINK! (LITERALLY) I wasn’t sure if I was going to tell my story. But

Researchers have created a fundamentally new class of HIV-fighting molecules by combining two separate antiviral mechanisms into a single engineered protein. Early laboratory results, reported

As reported on BioPharmaDive, UCB has reported positive results from a head-to-head clinical trial showing that its anti-inflammatory biologic Bimzelx was more effective than AbbVie’s
A diagnosis may explain part of your story, but it does not define your worth, your identity, or your future. You are still whole. Still you.
Today, and every day, remember:
Your life is bigger than a label.
Your voice matters.
Your existence is enough.
#youarenotyourdiagnosis #morethanmydiagnosis #chronicillnesscommunity #rarediseaseawareness #youareenough #PatientWorthy
... See MoreSee Less

World Psycho-Oncology Day recognizes the emotional and psychological side of cancer that is often less visible but just as important.
A cancer diagnosis can bring fear, uncertainty, stress, grief, and many complex emotions for both patients and their loved ones. Psycho-oncology focuses on understanding and supporting the mental and emotional challenges that can come with cancer, helping people navigate the psychological impact alongside the physical aspects of the disease.
Support, counseling, and compassionate care can make a meaningful difference in how people cope throughout their cancer journey.
Today is a reminder that caring for mental health is an essential part of cancer care.
#WorldPsychoOncologyDay #cancercare #cancersupport #mentalhealthmatters #PsychoOncology #PatientWorthy
... See MoreSee Less

Breaking Through Depression's Barriers: Real-World Evidence Demonstrates Spravato's Long-Term Effectiveness bit.ly/3PUzvib Read now at PatientWorthy.com
#PatientWorthy #majordepressivedisorder #MDD #Spravato
... See MoreSee Less

© Copyright 2024 Patient Worthy
Sign Up With a Patient Worthy Account and Share Your Rare Story
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.
What best describes you when it comes to rare disease? (check all that apply)
- OR -
Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.